Andrew Flyak
7Patents
1h-index
7Co-inventors
36Inventor score
Filing activity: Feb 25, 2016 → May 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10479825B2 | Antibody-mediated neutralization of Marburg virus | Chemistry; Metallurgy | 2 | Active |
| US11660332B2 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US11054423B2 | Antibody-mediated neutralization of ebolaviruses | Physics | 0 | Active |
| US11084869B2 | Antibody-mediated neutralization of Marburg virus | Chemistry; Metallurgy | 0 | Active |
| US10620204B2 | Antibody-mediated neutralization of Ebola viruses | Physics | 0 | Active |
| US12226471B2 | Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US11596679B2 | Hepatitis C virus gene sequences and methods of use therefor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.